量子テクノロジーのガバナンス: 標準を第一に考えるアプローチ
Mateo Aboy1,2, Urs Gasser3, I Glenn Cohen4
1Centre for Intellectual Property and Information Law, University of Cambridge, Cambridge, UK.
Science (New York, N.Y.)
|August 7, 2025
まとめ
グローバル・スタンダードは 初期段階の量子テクノロジーを管理するための 柔軟な枠組みを提供する. このアプローチは 量子技術開発のイノベーション,セキュリティ,国際協力のバランスをとります
科学分野:
- 量子技術
- 国際規格開発
- テクノロジーのガバナンス
背景:
- 初期段階の量子技術は 統治に独特の課題をもたらします
- 既存の規制の枠組みは 量子システムの急速な進歩に対応していないかもしれません
- グローバルに調和したアプローチの必要性はますます認識されています.
研究 の 目的:
- 初期段階の量子テクノロジーの柔軟でグローバルに調和したガバナンスモデルとして規格を提案する.
- セキュリティを保証しながら,そのような規格がイノベーションを促す方法について概要を述べる.
- 量子技術の開発における国際協力の役割を強調する.
主な方法:
- 量子技術の現状を分析する
- 既存の標準化プロセスの検討
- 国際技術ガバナンスモデルの比較研究
主要な成果:
- 標準は生まれつきの量子技術を 実行可能で適応可能な方法で 管理できます
- 調和したアプローチは,イノベーションとセキュリティのリスクを軽減することができます.
- 標準化は国際的な協力と信頼を促進します.
結論:
- 初期段階の量子技術の責任ある開発には,世界的な標準の導入が不可欠です.
- 標準はイノベーション,セキュリティ,協力における競合する利害を効果的に均衡させることができます.
- 量子技術分野では,標準に基づいた積極的なガバナンス戦略が推奨されています.
関連する概念動画
02:45The Quantum-Mechanical Model of an Atom
45.1K
Shortly after de Broglie published his ideas that the electron in a hydrogen atom could be better thought of as being a circular standing wave instead of a particle moving in quantized circular orbits, Erwin Schrödinger extended de Broglie’s work by deriving what is now known as the Schrödinger equation. When Schrödinger applied his equation to hydrogen-like atoms, he was able to reproduce Bohr’s expression for the energy and, thus, the Rydberg formula governing hydrogen spectra.
45.1K
01:28Global Regulatory Systems
73
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
73
01:25Ethical Standards I
971
The American Nurses Association (ANA) created and implemented the first nationally accepted Code of Ethics for Nurses with Interpretive Statements. The Code of Ethics is a living document regularly updated by the ANA and establishes an ethical standard that is non-negotiable for nurses in all roles and settings.
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...
971
01:23Ethical Standards II
798
Ethical standards are the backbone of nursing practice, guiding nurses as they interact with patients, families, and colleagues. These standards are crucial for providing safe, empathetic care centered on the patient's needs.
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...
798
02:43Quantum Numbers
38.0K
It is said that the energy of an electron in an atom is quantized; that is, it can be equal only to certain specific values and can jump from one energy level to another but not transition smoothly or stay between these levels.
38.0K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
246
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
246